Welcome to Santa Cruz Biotechnology!
  Protease Inhibitors
PRODUCTCATALOG #DESCRIPTIONAMOUNT
sc-203769
2-Guanidinoethylmercaptosuccinic Acid, also knowns as GEMSA, is a potent inhibitor of enkephalin convertase, known as a carboxypeptidase B-like processing enzyme.
5 mg
sc-203320
An electrophile used for covalent modification of cysteine, methionine, and histidine protein residues.
25 g
sc-203802
Aspartyl protease inhibitor that acts as an effective inhibitor of HIV-1 proteinase (Ki = 20 nM at pH 4.7) and HIV-2 proteinase (Ki = 5 nM at pH 4.7).
1 mg
sc-291906
A reversible inhibitor of Ser and Cys proteases with an activity spectrum comparable to leupeptin. H-1765 inhibited transformation of NIH3T3 cells after transfection with an activated H-ras oncogene. Has been employed for evaluating the role of proteases in the process of malignant transformation of BALB/c 3T3 cells.
5 mg/25 mg
sc-3595
Reversible inhibitor of esterase and serine protease activity such as trypsin, chymotrypsin, kallikrein, plasmin, urokinase, and leukocyte protease.
10 mg/100 mg
sc-202967
Shown to be an irreversible cysteine protease inhibitor that contains aziridine-2,3-dicarboxylic acid as a reactive agent. Also been reported to be active against plasmodial and lysosomal cysteine proteases.
2 mg
sc-202973
Inhibitor of serine protease enzymes.
5 g/25 g
sc-361130
Butabindide oxalate is a selective and potent inhibitor of tripeptidyl peptidase II.
10 mg/50 mg
sc-203867
Reported to be a protease and Trypsin inhibitor. Also shown to suppress spinal Fos expression in the rat and have direct regulatory effects on ductular cells of the dog pancreas.
10 mg/50 mg
sc-201312
A specific inhibitor of DPEP1, leukotriene D4 hydrolase and bacterial metallo-beta-lactamase. Exhibits nephroprotective effects in cyclosporine A-induced nephrotoxicity and is commonly used in conjunction with the antibiotic Imipenem (sc-205350).
10 mg/50 mg
sc-29131
EDTA-free mixture of several protease inhibitors that inhibit cysteine and serine, but not metalloproteases.
20 tablets
sc-29130
Mixture of several protease inhibitors with broad inhibitory specificity. Useful for inhibition of serine, cysteine, and metalloproteases.
20 tablets
sc-203922
Serine protease inhibitor. Irreversible inactivator of acetylcholinesterase that can cross the blood-brain barrier. Selectively blocks T cell receptor-triggered programmed cell death in murine T cell hybridoma and in activated peripheral T cells.
1 g
sc-202146
An antifibrinolytic agent which inhibits streptokinase and basic carboxypeptidases, but has been shown to enhance activation of urinary-type and tissue-type plasminogen.
500 g
sc-200826
Effective pancreatic lipase inhibitor derived from Streptomyces aburaviensis. Also inhibits hydrolysis of bradykinin and angiotensin (angiotensin I) through serine carboxypeptidase Y-like enzymes.
1 mg
sc-221575
A strong broad range inhibitor of serine proteases. Exhibits picomolar binding constant for the inhibition of chymotrypsin, elastase, Factor Xa, Factor XIIa, kallikrein, and trypsin. Also acts as an effective inhibitor of collagenase. Exhibits biological activity by binding trypsin in the picomolar range.
100 µg
sc-214965
A metallo-protease inhibitor with selectivity for aminopeptidases.
5 mg
sc-204014
A reagent shown to be used to modify cysteine residues in proteins to ultimately inhibit cysteine proteases.
25 g
sc-295238
This product inhibits protease, and inactivates chymotrypsin but does not inactivate trypsin. It has been shown to irreversibly inhibit chymotrypsin-like serine proteases including ficin, bromelain, and papain. It has also been shown to inhibits I kappaB alpha-protease. Inhibition of I kappaB alpha-protease blocks the LPS- or cytokine-induced activation of nuclear factor kappaB (NF-kappaB), which then blocks iNOS induction and COX-2 transcription. It is reported to block apoptosis cell lines through the inhibition of the processing of caspases in some cell lines and to some stimuli. It can also be used in histone isolation.
100 mg/250 mg
sc-215242
Produced by Actinomycetes and act as calpain, cysteine, and protease inhibitors. Studies show that Leupeptin preserves cardiac nitric oxide synthase 3 (NOS3).
5 mg/25 mg
sc-202707
Protein kinase C (PKC) activator. Second stage tumor promoter whereas phorbol-12-myristate 13-acetate (PMA) is a first stage tumor promoter. May be of use for studying phorbol ester receptor isotypes. Induces interleukin-1α. Coinducer of interferon with phytohemagglutinin.
1 mg
sc-201307
A highly effective tryptase (Ki=95.3 pM) inhibitor that can promote synthesis of interferon-gamma, tumor necrosis factor-alpha, IL-12, and IL-18.
10 mg/50 mg
sc-222101
10 mg
sc-204155
An irreversible and specific protease inhibitor that blocks intracellular acidification, DNA fragmentation, and 5-Fluoro-2'-deoxyuridine induced cell death.
5 mg
sc-222151
1 mg/5 mg
sc-201283
An inhibitor of the metalloprotease NEP and its homologue NEP2, which both belong to a group of type II integral membrane glycoproteins.
5 mg/25 mg
sc-203215
A potent, specific and irreversible inhibitor of glandular and plasma kallikreins. Inhibits rat adrenal kininogenase and inactivates native human hageman factor.
10 mg
sc-264149
Inhibits cysteine and serine proteases.
25 mg/100 mg
sc-201287
An enkephalinase and metalloproteinase inhibitor that shows antinociceptive activity. Displays antiapoptotic and proliferative protective effects.
5 mg/25 mg
sc-201296
Irreversibly inhibits trypsin-like serine proteases such as granzyme D. Inhibits LPS-induced expression of COX-2 in macrophages and the chymotrypsin- and trypsin-like activity of the proteasome.
200 mg
sc-201297
A potent serine and cysteine protease inhibitor, disables NF-κB activation and subsequently shuts down COX-2 activity.
1 g
sc-204358
Specific, reversible inhibitor of trypsin. Also inhibits human Factor XIIa. May function in host resistance against fungal pathogens in crops.
1 mg
sc-311559
A novel cysteine protease inhibitor that specifically and efficiently inhibits processing of the p-Prl signal peptide.
5 mg

High quality protease inhibitors are provided as individual inhibitors and as cocktails to effectively protect proteins from a broad range of unwanted protease activity including serine, cysteine, and metelloproteases. One unit of activity is defined as the amount of enzyme that converts 1 µmol of substrate to product in one minute under the given assay conditions. Complete Protease Inhibitor Cocktail Tablet and Complete Protease Inhibitor Cocktail Tablet, EDTA-free are trademarks of Roche Applied Science.